NCT05857956 is a NA clinical trial of Proper Wild energy shot in ADHD, sponsored by Proper Wild, Inc..

Who is sponsoring NCT05857956?

NCT05857956 is sponsored by Proper Wild, Inc..

What drugs are being tested in NCT05857956?

Interventions in NCT05857956: Proper Wild energy shot.

What condition does NCT05857956 study?

NCT05857956 studies ADHD, Attention Difficulties, Mood, Anxiety, Caffeine.

Is NCT05857956 still recruiting?

NCT05857956 is currently completed. Last updated 15 May 2023.

Last reviewed 2023-05-15 · How we verify

NCT05857956

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Clinical Trial to Assess the Efficacy of a Plant-based Energy Shot on Focus and ADHD-like Symptoms

Completed NA Last updated 15 May 2023

What this trial tests

NA trial testing Proper Wild energy shot in ADHD in 40 participants. Completed in 11 April 2023.

Timeline

24 February 2023

Primary endpoint
7 April 2023

11 April 2023

Quick facts

Lead sponsor	Proper Wild, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	40
Start date	24 February 2023
Primary completion	7 April 2023
Estimated completion	11 April 2023
Sites	1 location across United States

Drugs / interventions tested

Proper Wild energy shot

Conditions studied

ADHD — all drugs for ADHD →
Attention Difficulties — all drugs for Attention Difficulties →
Mood — all drugs for Mood →
Anxiety — all drugs for Anxiety →

Sponsor

Proper Wild, Inc.

Who can join

Adults 18 to 55, any sex, with ADHD or Attention Difficulties. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a virtual, single-arm clinical trial that will last 28 days. Participants will drink 1 bottle of Proper Wild energy shot daily and complete questionnaires at baseline, day 1, day 14, and day 28. Attention deficit hyperactivity disorder (ADHD)-like symptoms, such as concentration, focus, and attention, will be evaluated at baseline and at each check-in. Likert scale responses will be examined from baseline to each check-in. Participant responses on product feedback will be presented as % scores.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for ADHD

Currently open trials in the same condition.

NCT07314333 — A Trial to Assess How Centanafadine Interacts With Stimulants in the Body · Phase 1 · recruiting
NCT07262853 — Dual Executive Function Training Package · NA · recruiting
NCT07291453 — Loving Habits: A Feasibility Study of a Support Program for Building New Parent-child Behavioral Habits · NA · recruiting
NCT07281092 — Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) · NA · recruiting
NCT07219810 — Accelerated iTBS Targeting of Working Memory Versus Inhibitory Control in Adolescent ADHD · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05857956 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Proper Wild, Inc.
Last refreshed: 15 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05857956.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing